The conference highlighted strong operational progress, significant bed growth, and ongoing investments in quality and technology. Despite 2025 financial headwinds from payer pressure and regulatory changes, the company expects ramping new facilities, reduced CapEx, and enhanced execution to drive EBITDA and free cash flow growth in 2026 and beyond.
Disclaimer
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.